Cost-effectiveness of long-term oxygen therapy for chronic obstructive pulmonary disease

American Journal of Managed Care

Volumn 15, Issue 2, 2009, Pages 97-104

  Oba, Yuji ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COR PULMONALE; COST EFFECTIVENESS ANALYSIS; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM CARE; MEDICARE; OXYGEN THERAPY; POLYCYTHEMIA; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS;

COST-BENEFIT ANALYSIS; HUMANS; MARKOV CHAINS; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 61849100536     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1980;93(3):391-398.
2. Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet. 1981 ;1 (8222): 681-686.
3. 2 above 60 mm Hg. Am Rev Respir Dis. 1992;145(5):1070-1076.
4. Chaouat A, Weitzenblum E, Kessler R, et al. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J. 1999;14(5):1002-1008.
5. Ward MM, Javitz HS, Smith WM, Bakst A. Direct medical cost of chronic obstructive pulmonary disease in the U.S.A. Respir Med. 2000;94(11):1123-1129.
6. CroxtonTL, Bailey WC. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am J Respir Crit Care Med. 2006;174(4):373-378.
7. U.S. Government Accountability Office Web site. Department of Health and Human Services, Centers for Medicare and Medicaid Services: Medicare program; home health prospective payment system rate update for calendar year 2007 and Deficit Reduction Act of 2005 changes to Medicare payment for oxygen equipment and capped rental durable medical equipment, GAO-07-230R, November 22, 2006. http://www.gao.gov/decisions/majrule/d07230r.htm. Accessed May 2008.
8. Gorecka D, Gorzelak K, Sliwinski RTobiasz M, Zielinski J. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax. 1997;52(8):674-679.
9. Haidl P, Clement C, Wiese C, Dellweg D, Kohler D. Long-term oxygen therapy stops the natural decline of endurance in COPD patients with reversible hypercapnia. Respiration. 2004;71(4):342-347.
10. Beck JR, Pauker SG, Gottlieb JE, Klein K, Kassirer JR A convenient approximation of life expectancy (the "DEALE"), II: use in medical decision-making. Am J Med. 1982;73(6);889-897.
11. Karisson G, Johannesson M. The decision rules of cost-effectiveness analysis. Pharmacoeconomics. 1996;9(2):113-120.
12. Rutten-van Mölken MP, Oostenbrink JB. Tashkin DP, Burkhart D, Monz BU. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest. 2006;130(4):1117-1128.
13. Centers for Medicare & Medicaid Services Web site. Fee schedule update for 2007 for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS). http://www.cms.hhs.gov/MLNMattersArticles/downloads/ MM5417.pdf. Accessed May 2008.
14. Respiratory Management Web site. Oxygen + power: hidden costs and risks for stationary concentrator users. July 10, 2007. http.//www. respiratorymgmt.com/articles/49074. Accessed May 2008.
15. Reisfield GM, Wilson GR. The cost of breathing: an economic analysis of the patient cost of home oxygen therapy. Am J Hosp Palliat Care, 2004;21(5):348-352.
16. Saag MS. HIV resistance testing in clinical practice: a QALY-fied success. Ann Intern Med. 2001;134(6):475-477.
17. Koplan JP, Harpaz R. Shingles vaccine: effective and costly or cost-effective? Ann Intern Med. 2006;145(5):386-387.
18. Roberts SD. Cost-effective oxygen therapy. Ann Intern Med. 1980;93(3):499-500.
19. Stewart BN, Hood CI, Block AJ. Long-term results of continuous oxygen therapy at sea level. Chest. 1975;68(4):486-492.
20. Ramsey SD, Shroyer AL, Sullivan SD, Wood DE. Updated evaluation of the cost-effectiveness of lung volume reduction surgery. Chest. 2007;131(3):823-832.
21. Ramsey SD, Berry K, Etzioni R, Kaplan RM, Sullivan SD, Wood DE. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med. 2003;348(21):2092-2102.
22. Ramsey SD, Patrick DL, Albert RK, Larson EB, Wood DE, Raghu G; University of Washington Medical Center Lung Transplant Study Group. The cost-effectiveness of lung transplantation: a pilot study. Chest. 1995;108(6):1594-1601.
23. 1,-antitrypsin deficiency. Am J Respir Crit Care Med. 2003;167(10):1387-1392.
24. Oba Y. Cost-effectiveness of long-acting bronchodilators for chronic obstructive pulmonary disease. Mayo Clin Proc. 2007;82(5):575-582.
25. Sin DD, Golmohammadi K, Jacobs R Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity. Am J Med. 2004;116(5):325-331.
26. Toevs CD, Kaplan RM, Atkins CJ. The costs and effects of behavioral programs in chronic obstructive pulmonary disease. Med Care. 1984;22(12|:1088-1100.
27. Morrison Informatics, Inc. A comprehensive cost analysis of Medicare home oxygen therapy: a study for the American Association for Homecare. June 27, 2006. http://www.aahomecare.org/associations/3208/files/ Morrison%20Oxygen%20Cost%20Study%20Report%20 June%2027%202006.pdf. Accessed May 2008.
28. Department of Health and Human Services Office of the Inspector General. Medicare home oxygen equipment: cost and servicing. September 2006. http://oig.hhs.gov/oei/reports/oei-09-04-00420.pdf. Accessed May 2008.
29. U.S. Department of Health and Human Services, National Institutes of Health. NIH news: NHLBI and CMS launch large study of home oxygen therapy for COPD: clinical trial will clarify if more patients could benefit from treatment. November 20, 2006. http.//www.nhlbi.nih.gov/new/press/06-11-20.htm. Accessed May 2008.
30. Eisner MD, Yelin EH,Trupin L, Blanc PD. The influence of chronic respiratory conditions on health status and work disability. Am J Public Health. 2002;92(9):1506-1513.
31. RingbaekTJ, Viskum K, Lange P. Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease? Eur Respir J. 2002;20(1 ):38-42.
32. Crockett AJ, Moss JR, Cranston JM, Alpers JH. The effects of home oxygen therapy on hospital admission rates in chronic obstructive airways disease. Monaldi Arch Chest Dis. 1993;48(5):445-446.
33. Clini E.Vitacca M, Foglio K, Simoni P, Ambrosino N. Long-term home care programmes may reduce hospital admissions in COPD with chronic hypercapnia. Eur Respir J. 1996;9(8):1605-1610.
34. Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol. 2005:34(1 ):215-220.
35. Heaton RK, Grant I, McSweeny AJ, Adams KM, PettyTL. Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1983;143(10):1941-1947.
36. Ringbaek TJ. Continuous oxygen therapy for hypoxic pulmonary disease: guidelines, compliance and effects. Treat Respir Med. 2005;4(6):397-408.
37. Guyatt GH, Nonoyama M, Lacchetti C, et al. A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy. Am J Respir Crit Care Med. 2005;172(5):573-580.